NDC 51662-1430

TIGAN(R) (TRIMETHOBENZAMIDE HYDROCHLORIDE)

Tigan(r) (trimethobenzamide Hydrochloride)

TIGAN(R) (TRIMETHOBENZAMIDE HYDROCHLORIDE) is a Intramuscular Injection in the Human Prescription Drug category. It is labeled and distributed by Hf Acquisition Co Llc, Dba Healthfirst. The primary component is Trimethobenzamide Hydrochloride.

• Product ID: 51662-1430_9bd0bfa0-c18a-751c-e053-2a95a90a5f5a
• NDC: 51662-1430
• Product Type: Human Prescription Drug
• Proprietary Name: TIGAN(R) (TRIMETHOBENZAMIDE HYDROCHLORIDE)
• Generic Name: Tigan(r) (trimethobenzamide Hydrochloride)
• Dosage Form: Injection
• Route of Administration: INTRAMUSCULAR
• Marketing Start Date: 2020-01-10
• Marketing Category: NDA / NDA
• Application Number: NDA017530
• Labeler Name: HF Acquisition Co LLC, DBA HealthFirst
• Substance Name: TRIMETHOBENZAMIDE HYDROCHLORIDE
• Active Ingredient Strength: 100 mg/mL
• Pharm Classes: Antiemetic [EPC],Emesis Suppression [PE]
• NDC Exclude Flag: N
• Listing Certified Through: 2021-12-31

Packaging

NDC 51662-1430-1

2 mL in 1 VIAL, SINGLE-DOSE (51662-1430-1)

• Marketing Start Date: 2020-01-10
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 51662-1430-1 [51662143001]

TIGAN(R) (TRIMETHOBENZAMIDE HYDROCHLORIDE) INJECTION

• Marketing Category: NDA
• Application Number: NDA017530
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2020-01-10

Drug Details

Active Ingredients

Ingredient	Strength
TRIMETHOBENZAMIDE HYDROCHLORIDE	100 mg/mL

Pharmacological Class

• Antiemetic [EPC]
• Emesis Suppression [PE]